<?xml version="1.0" encoding="UTF-8"?>
<p id="p0195">Darunavir is another anti-retroviral protease inhibitor that often uses in combination with other cytochrome P450 inhibitors, such as ritonavir or cobicistat, for the treatment of HIV infection [
 <xref rid="bb0715" ref-type="bibr">143</xref>]. The in-vitro studies suggested the inhibitory action of SARS-CoV-II replication [
 <xref rid="bb0720" ref-type="bibr">144</xref>]. It is still under the evaluation trials for the efficacy against COVID-19 [
 <xref rid="bb0560" ref-type="bibr">112</xref>].
</p>
